Repurposing nucleoside reverse transcriptase inhibitors (NRTIs) to slow aging

Abstract excerpt

Repurposing drugs already approved in the clinic to be used off-label as geroprotectors, compounds that combat mechanisms of aging, are a promising way to rapidly reduce age-related disease incidence in society. Several recent studies have found that a class of drugs-nucleoside reverse transcriptase inhibitors (NRTIs)-originally developed as treatments for cancers and human immunodeficiency virus (HIV) infection,...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Adenosine and Purinergic Signaling
• Share to Cytomegalovirus and herpesvirus research
• Share to Genetics and Neurodevelopmental Disorders